Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1998Expert Opinion on Investigational Drugs

Tyrosine kinases in disease: overview of kinase inhibitors as therapeutic agents and current drugs in clinical trials

View Full Paper
Ask AI
Bookmark
Share

Authors

LSLaurie M. StrawnPfizer (United States)LSLaura K. ShawverSanofi (Turkey)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Strawn et al. (1998) studied this question.

synapsesocial.com/papers/6a10c7c58102eb4b66ee628chttps://doi.org/10.1517/13543784.7.4.553
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Expression of the Fgf6 gene is restricted to developing skeletal muscle in the mouse embryo1993 · 135 citations
  2. 2Molecular Cloning of a Novel Cytokine cDNA Encoding the Ninth Member of the Fibroblast Growth Factor Family, which has a Unique Secretion Property1993 · 390 citations
  3. 3erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 Cells1987 · 1,019 citations